Pulmonx Corporation provided earnings guidance for the full year 2023. The company continues to expect revenue for the full year 2023 to be in the range of $63 million to $65 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.07 USD | -3.70% | -10.33% | -36.71% |
01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
01/05 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.71% | 31Cr | |
+75.35% | 1.25TCr | |
-23.01% | 750.72Cr | |
+8.35% | 674.19Cr | |
+14.40% | 547.33Cr | |
-14.85% | 488.61Cr | |
+32.74% | 473.87Cr | |
-25.57% | 369.54Cr | |
-23.06% | 290.4Cr | |
+55.06% | 249.12Cr |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Earnings Guidance for the Full Year 2023